LEADER 02568nam 2200373 450 001 9910674040803321 005 20230623095109.0 035 $a(CKB)4100000011302167 035 $a(NjHacI)994100000011302167 035 $a(EXLCZ)994100000011302167 100 $a20230623d2020 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aBiomedical Insights that Inform the Diagnosis of ME/CFS /$fedited by Brett Lidbury, Paul Fisher 210 1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2020. 215 $a1 online resource (202 pages) 311 $a3-03928-390-1 330 $aMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe chronic health condition that is often misunderstood or ignored by health establishments. The lack of definitive diagnostic markers to separate ME/CFS patients from the healthy population as well as from other chronic disorders is problematic for both health professionals and researchers. A consortium of Australian researchers gathered to systematically understand ME/CFS, ranging from a deep analysis of clinical and pathology data to metabolomic profiles and the investigation of mitochondrial function. From this broad collaboration, a number of compelling insights have arisen that may form the basis of specific serum, blood, and/or urinary biomarkers of ME/CFS. This Special Edition reports on a conference centred on these biomedical discoveries, with other contributions, with a translation focus for predictive markers for ME/CFS diagnosis. By supporting health professionals with developments in diagnostics for this condition, the patients and their families will hopefully benefit from an improved recognition of the biomedical underpinnings of the condition and will be better able to access the care that is urgently required. This Special Edition contains a mix of speaker submissions and other accepted manuscripts that contributed to our objective of advancing biomedical insights to enable the accurate diagnosis of ME/CFS. 606 $aMedicine$vEarly works to 1800 606 $aMedicine$xPractice 615 0$aMedicine 615 0$aMedicine$xPractice. 676 $a610.8 702 $aLidbury$b Brett A. 702 $aFisher$b Paul 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910674040803321 996 $aBiomedical Insights that Inform the Diagnosis of ME$92945147 997 $aUNINA